IACP is an association representing more than 4,000 pharmacists, technicians, students, and members of the compounding community who focus upon the specialty practice of pharmacy compounding. Pharmacy compounding is the long-established tradition in pharmacy practice that enables physicians to prescribe and patients to take medicines that are specially prepared by pharmacists to meet patients’ individual needs.
“Having the clinical and professional expertise of individuals such as Shawn Hodges is essential to IACP’s role in developing the best practices of compounding pharmacists everywhere,” says, IACP President Erik Tosh, DPh, FIACP, FACA. “Each of our volunteer Board members brings unique experience as both practitioners and business managers to guide IACP and its membership. We are fortunate to have Shawn as part of our leadership team, and an integral part of our effort to preserve patient access to compounded medications.”
After graduating from Texas Tech School of Pharmacy in 2001, Dr. Hodges was accepted into a one-year visiting scientist program with Eli Lilly. Located next to the Food & Drug Administration (FDA), he served as a liaison between Eli Lilly and FDA, sharing FDA’s thoughts to the regulatory team at Lilly headquarters. Upon completion, he worked for Hospice Pharmacia, consulting with prescribers about the appropriate use of hospice- related medications. In 2007, Dr. Hodges purchased Innovation Compounding, and currently provides both sterile and non-sterile compounded preparations.
In addition to serving on the IACP Board, he is the Chair of IACP’s COMP PAC, a member of the American Pharmacists Association, Georgia Pharmacists Association, Phi Delta Chi as both an Alumnus and Chapter Advisor, and Phi Lambda Sigma as a Charter Member.
Shawn Hodges adds, “It’s an honor to support both our fellow compounding pharmacists as well as our patients’ healthcare needs. It’s imperative that both physicians and patients have the right to access medications that can help bridge the gap between living and living well. By working with IACP leadership, we can make a considerable positive impact in the direction of pharmacy compounding.”
To learn more about IACP and its efforts to protect patients’ and physicians’ access to compounded medications, visit their website here.